On August 11, 2023, Elevar Therapeutics, Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
48,500 KRW | +3.19% | -50.51% | -4.34% |
1st Jan change | Capi. | |
---|---|---|
-4.34% | 4.51B | |
-6.62% | 180B | |
+3.03% | 112B | |
-3.48% | 68.53B | |
+5.42% | 51.97B | |
+5.72% | 44.08B | |
+5.62% | 42.23B | |
+23.80% | 32.43B | |
+16.72% | 26.39B | |
-3.54% | 24.97B |
- Stock Market
- Equities
- A028300 Stock
- News HLB Co., Ltd.
- Elevar Therapeutics, Inc. announced that it has received KRW 58.174676146 billion in funding from HLB Co., Ltd.